Nuwellis Q2 2025 revenue down 23% YoY to $1.7M; net loss widens to $12.6M

Nuwellis, Inc.

2025-Q2 EPS reported -$100.44 revenue$3,629,000

Revenue $1.7M vs $2.2M in Q2 2024; decline due to sterilization vendor backorder.
Gross margin fell to 55.5% from 67.2%; operating loss $2.9M vs $2.3M.
Net loss attributable to common shareholders $12.6M ($60.99/share) vs $7.7M ($791.82).
Cash $4.5M; debt-free; completed $5.0M gross capital raise in Q2.
Outsourced manufacturing to KDI Precision; added two pediatric centers (47 total); new patent on fluid bag design.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.